Galapagos therapeutics
WebI am a R&D professional with over than 10 years of Life Sciences industries experience. I held various leading research positions at Proskelia (2002-2004), Prostrakan (2004-2006) and Galapagos (2007-2012) and as associate research director at Addex Therapeutics (2012-2013, Geneva). I followed the startup training program of Linksium (Grenoble) in … WebDec 14, 2024 · Ryvu announces option to license inflammation program exercised by Galapagos NV. KRAKOW, Poland, Dec. 14, 2024 /PRNewswire/ -- Ryvu Therapeutics S.A. (WSE: RVU) announced today that the pre-agreed ...
Galapagos therapeutics
Did you know?
WebSep 17, 2024 · Galapagos NV discovers, develops, and commercializes small molecule medicines with novel modes of action. Our pipeline comprises discovery through Phase 3 programs in inflammation, fibrosis, and ... WebCurrently managing M&A strategy and business development transactions at Galapagos. Strong 7+ years experience in business development, competitive intelligence & corporate strategy. Solid understanding of the ins and outs of the biotech industry. Previously exposed to public, private & private equity companies across the full drug development spectrum; …
WebThrough the acquisition of CellPoint and AboundBio, respectively, Galapagos gains access to an innovative, scalable, decentralized and automated point-of-care cell therapy supply … WebFeb 2, 2024 · Mechelen, Belgium; 2 February 2024, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) will present data at the European Crohn’s and Colitis Organization …
WebMar 22, 2024 · Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo ... WebJun 22, 2024 · In addition, AboundBio will receive $14m from Galapagos under the agreed transaction. Galapagos obtains access to a scalable, …
WebApr 16, 2024 · Mechelen, Belgium and Krakow, Poland; 16 April 2024, 07.30 CET – Galapagos NV (Euronext & NASDAQ: GLPG) and Ryvu Therapeutics S.A. (WSE: RVU) today announced a collaboration focused on the discovery and development of novel small molecule drugs in inflammation.. Ryvu specializes in the discovery and development of …
WebAug 19, 2024 · The FDA’s decision drove Galapagos down as much as 33%, wiping more than 3 billion euros ($3.6 billion) off its market value. Gilead shares fell as much as 4.4% in the U.S. LIVE ON BLOOMBERG black toe diabeticWebAug 12, 2024 · About Galapagos Galapagos NV discovers and develops small molecule medicines with novel modes of action, three of which show promising patient results and are currently in late-stage development in multiple diseases. Our pipeline comprises discovery through Phase 3 programs in inflammation, fibrosis, osteoarthritis and other indications. foxeer xat700m camera mountsWebFeb 2, 2024 · Mechelen, Belgium; 2 February 2024, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) will present data at the European Crohn’s and Colitis Organization (ECCO) annual congress taking place 16-19 ... black toe cuticleWebJan 16, 2024 · Galapagos has expanded its research collaboration with Candian firm Fibrocor Therapeutics, which develops tissue-specific therapeutics for fibrotic … fox ego haslingtonWebGalapagos, Inc. 245 Main Street 02142 Cambridge, Massachusetts United States. Get Directions . Galapagos GmbH Aeschengraben 27 4051 Basel Switzerland Email: [email protected]. Get Directions . Galapagos B.V. Willem Einthovenstraat 13 2342 BH Oegstgeest, Netherlands Tel: +31 71 7996167 www.glpg.nl. foxeer wildfire manualWebMar 11, 2024 · WARSAW, Poland, March 11, 2024 /PRNewswire/ -- OncoArendi Therapeutics S.A. ... OncoArendi has an exclusive collaboration and license agreement with Galapagos for the global development and ... black toed monitorWebJun 10, 2024 · Oxford, UK, 10 th June 2024: e-therapeutics plc (AIM: ETX.L, “e-therapeutics” or “the Company”) today announces that it has entered a collaboration agreement with Galapagos NV (“Galapagos”) to identify new therapeutic approaches to modulate a specific mechanism involved in idiopathic pulmonary fibrosis (IPF) and … black toe and finger nails